Purchase Order 12805B23P0130

The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...

The Department of Health and Human Services Food and Drug Administration awarded a $40,000 firm fixed price delivery order against its IDIQ contract for Proteomics of Human Plasma and/or Serum. Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., will provide plasma proteomic assay services per sample under the terms of this order. Performance will take place in Silver Spring, Maryland through August 31, 2022. No set-aside designation was applied to this award made in...

The U.S. Food and Drug Administration (FDA) awarded a $106,675.00 firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a proteomic analysis of cancer patient plasma samples. The contract, which has no set-aside designation, will be performed at Olink's facility in Waltham, Massachusetts and involves the comprehensive analysis of over 5,000 proteins across 100 plasma samples using Olink's advanced multiplex immunoassay...

This task order, awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA), calls for $470,000 in proteomics analysis services of human serum or plasma from Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The firm fixed price delivery order has a period of performance through August 31, 2022 and was awarded on September 30, 2020 without a set-aside designation. The place of performance will be Silver Spring, Maryland, where the HHS...

This is a $79,345.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for quantitative proteomics measurement of human COVID-19 plasma samples, which supports the FDA's research efforts related to the COVID-19 pandemic. Olink Proteomics specializes in protein biomarker discovery and has provided a range of proteomics instruments, reagents, and analysis services to various...

This is a $24,940 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit genomics and molecular biology services company. The contract is to provide plasma protein detection services using a proteomics platform to support NHLBI's ongoing clinical protocol for sickle cell disease research. The contract period of performance is from June 15, 2025 to December 14, 2025. No set-aside designation was...

The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...

The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $36,950.00 firm fixed-price purchase order to Proteinsimple, also known as Bio-Techne Corporation Division, for a PROTEIN SIMPLE MULTIFLOUR SYSTEM. This award, which did not use a set-aside, supports critical biomedical research and drug development initiatives across various government agencies. Proteinsimple is a leading manufacturer and provider of...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $566,800 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract calls for the delivery of an aptamer-based proteomic assay to measure approximately 7,000 proteins in approximately 872 human plasma samples from the Nutrition for Precision Health cohort. The assay results will identify proteomic signatures that predict...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $14,148 purchase order to Proteinsimple, a division of Bio-Techne Corporation, to deliver SIMPLE PLEX CARTRIDGE KITS FOR 32 SAMPLES. The firm fixed price order is for the delivery of sample cartridge kits to support research activities at the agency's Bethesda, Maryland campus. Performance will take place over approximately seven weeks from mid-August through late September of 2023. No...